Cargando…

Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome

Detalles Bibliográficos
Autores principales: Abu-Zeinah, Ghaith, Di Giandomenico, Silvana, Choi, Daniel, Cruz, Tatiana, Erdos, Katie, Taylor, Elwood, Ritchie, Ellen K., Silver, Richard T., Scandura, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631704/
https://www.ncbi.nlm.nih.gov/pubmed/35789232
http://dx.doi.org/10.1182/bloodadvances.2022007128
_version_ 1784823873258127360
author Abu-Zeinah, Ghaith
Di Giandomenico, Silvana
Choi, Daniel
Cruz, Tatiana
Erdos, Katie
Taylor, Elwood
Ritchie, Ellen K.
Silver, Richard T.
Scandura, Joseph M.
author_facet Abu-Zeinah, Ghaith
Di Giandomenico, Silvana
Choi, Daniel
Cruz, Tatiana
Erdos, Katie
Taylor, Elwood
Ritchie, Ellen K.
Silver, Richard T.
Scandura, Joseph M.
author_sort Abu-Zeinah, Ghaith
collection PubMed
description
format Online
Article
Text
id pubmed-9631704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-96317042022-11-04 Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome Abu-Zeinah, Ghaith Di Giandomenico, Silvana Choi, Daniel Cruz, Tatiana Erdos, Katie Taylor, Elwood Ritchie, Ellen K. Silver, Richard T. Scandura, Joseph M. Blood Adv Research Letter American Society of Hematology 2022-09-26 /pmc/articles/PMC9631704/ /pubmed/35789232 http://dx.doi.org/10.1182/bloodadvances.2022007128 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
Abu-Zeinah, Ghaith
Di Giandomenico, Silvana
Choi, Daniel
Cruz, Tatiana
Erdos, Katie
Taylor, Elwood
Ritchie, Ellen K.
Silver, Richard T.
Scandura, Joseph M.
Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
title Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
title_full Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
title_fullStr Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
title_full_unstemmed Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
title_short Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
title_sort hematopoietic fitness of jak2(v617f) myeloproliferative neoplasms is linked to clinical outcome
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631704/
https://www.ncbi.nlm.nih.gov/pubmed/35789232
http://dx.doi.org/10.1182/bloodadvances.2022007128
work_keys_str_mv AT abuzeinahghaith hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT digiandomenicosilvana hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT choidaniel hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT cruztatiana hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT erdoskatie hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT taylorelwood hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT ritchieellenk hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT silverrichardt hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome
AT scandurajosephm hematopoieticfitnessofjak2v617fmyeloproliferativeneoplasmsislinkedtoclinicaloutcome